Seaport Therapeutics
SPTX
17.93
+0.56
+3.22%
Seaport Therapeutics
US · SPTX
#3277 by market cap
Listed 2026
17.93
+0.56
+3.22%
Live - 5344 symbols - heartbeat 295s ago
· 2026-10-07 20:02
After-hours
17.93
0.00%
- Market cap
- 959.80M
- P/E (TTM)i
- -7.13
- P/Bi
- 2.27
- EPSi
- -1.41
- Div yieldi
- 0.00%
- 52W posi
- 23%
Reader sentiment
Are you bullish or bearish on SPTX?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
J.P. Morgan Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $42Market Newswire · 2026/6/9
-
JonesTrading Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $32Market Newswire · 2026/8/26
-
Citi Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/9/10
-
Rating change
Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)TipRanks · 2026/6/9
-
Rating change
Stifel Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $30Market Newswire · 2026/5/26
-
H.C. Wainwright Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $50Market Newswire · 2026/9/10
-
Rating change
J.P. Morgan Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $42Market Newswire · 2026/5/27
-
Rating change
Leerink Partners Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $35Market Newswire · 2026/5/26
-
Rating change
Leerink Partners Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35Market Newswire · 2026/5/28
-
Rating change
Wolfe Research Initiates Seaport Therapeutics(SPTX.US) With Hold RatingMarket Newswire · 2026/7/7
-
Rating change
Stifel Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $30Market Newswire · 2026/8/14
-
Rating change
Citi Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $35Market Newswire · 2026/5/26
-
JonesTrading Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $32Market Newswire · 2026/9/10
-
Rating change
H.C. Wainwright Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $50Market Newswire · 2026/7/16
-
Rating change
Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)TipRanks · 2026/6/2
-
Rating change
Analysts Conflicted on These NA Names: SailPoint, Inc. (SAIL) and Seaport Therapeutics, Inc. (SPTX)TipRanks · 2026/9/10
-
Analysts Offer Insights on NA Companies: Seaport Therapeutics, Inc. (SPTX), Navan, Inc. Class A (NAVN) and International Business Machines (IBM)TipRanks · 2026/9/10
-
Rating change
Seaport Therapeutics, Inc. (SPTX) Gets a Buy From Stifel NicolausTipRanks · 2026/8/13
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 20:02:48 · For reference only, not investment advice and not tailored to your situation.